Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Industry Impact

Incentives

  • Providing review of mappings

  • Requirements in regulations (for example support for keeping mappings updated to the latest version of the mapped to standards)

  • Like to see that data instances of test data is being collected for regulatory use – so FDA would need to share the requirements

  • Industry is being asked by customers to provide LOINC mapping (not so much SNOMED codes yet) because there is a requirement for reporting to PH as well as for MU to have the tests be represented using LOINC

  • ONC should clearly state that LOINC mapping is still required and needs to be maintained

Issues

  • Vendors thought that the FDA would hold them accountable for encouraging “off-label use” based on the interpretation of the LOINC code(s) published

  • Vendors may want to limit access to their mappings to paying customers only (or at least know who is downloading LIVD files)

  • Vendors operate internationally, so need to ensure mappings are not just US regulation focused

Standards Development Issues

  • Ensure the LOINC - SNOMED CT collaborative agreement and how to deal with differences in approaches

Format Considerations

...

  • Current format is spreadsheet for manual review and use

...

  • Future formats should

    • support automatic mapping, if possible

    • support mapping assistance for manual selection

    • be more easily searchable